2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow ProMune: new trials by email Literature Review of ProMune trials Research Report on ProMune
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer PF-3512676 + Paclitaxel + Carboplatin, Paclitaxel + Carboplatin - Carcinoma, Non-Small-Cell Lung | Phase 3 | Terminated | Pfizer | 828 | 2005-11-01 | 2015-03-30 |
| Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC Cisplatin, Gemcitabine, PF-3512676 - Carcinoma, Non-Small-Cell Lung | Phase 3 | Terminated | Pfizer | 839 | 2005-11-01 | 2015-03-30 |
Carcinoma, Non-Small-Cell Lung (2)
Pfizer (2)
Belgium (2) · Canada (2) · China (2) · Czechia (2) · Germany (2) · Hong Kong (2) · Hungary (2) · India (2) · Israel (2) · Italy (2) · Netherlands (2) · Poland (2) · Portugal (2) · South Africa (2) · South Korea (2)